There are two Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis.
View Top Employees from Otsuka Pharmaceutical Companies (U.S.)Website | http://www.otsuka-us.com |
Revenue | $3.78 billion |
Employees | 3,714 (3,714 on RocketReach) |
Founded | 1989 |
Address | 508 Carnegie Center, Princeton, New Jersey 08540, US |
Phone | (301) 424-9055 |
Technologies |
JavaScript,
HTML,
PHP
+215 more
(view full list)
|
Category | Pharmaceutical Manufacturing, Pharmaceuticals, Health Care, Neuroscience, Healthcare, Medical, Cardiovascular, Oncology, Medical Devices |
Web Rank | 1 Million |
Keywords | otsuka, otsuka pharmaceutical, abilify maintena fda approvval, otsuka abilify maintena, otsuka digital theraptutics |
Competitors | Astellas Pharma India Private Limited, Athenex, Ipsen, Nektar Therapeutics, OPKO Health, Inc. |
SIC | 283, 28 |
NAICS | 325, 32, 32541, 3254 |
Looking for a particular Otsuka Pharmaceutical Companies (U.S.) employee's phone or email?
The Otsuka Pharmaceutical Companies (U.S.) annual revenue was $3.78 billion in 2023.
Zack Zazula is the Chief Information Security Officer of Otsuka Pharmaceutical Companies (U.S.).
3,714 people are employed at Otsuka Pharmaceutical Companies (U.S.).
Otsuka Pharmaceutical Companies (U.S.) is based in Princeton, New Jersey.
The NAICS codes for Otsuka Pharmaceutical Companies (U.S.) are [325, 32, 32541, 3254].
The SIC codes for Otsuka Pharmaceutical Companies (U.S.) are [283, 28].